Ray Co., Ltd. (KOSDAQ:228670)
4,470.00
-155.00 (-3.35%)
Sep 21, 2026, 3:30 PM KST
Ray Co., Ltd. Revenue
Ray Co., Ltd. had revenue of 34.15B KRW in the quarter ending June 30, 2026, with 24.14% growth. This brings the company's revenue in the last twelve months to 119.17B, up 32.85% year-over-year. In the year 2025, Ray Co., Ltd. had annual revenue of 111.32B with 39.43% growth.
Revenue (ttm)
119.17B
Revenue Growth
+32.85%
P/S Ratio
0.59
Revenue / Employee
731.11M
Employees
163
Market Cap
69.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 111.32B | 31.48B | 39.43% |
| Dec 31, 2024 | 79.84B | -66.04B | -45.27% |
| Dec 31, 2023 | 145.88B | 16.88B | 13.09% |
| Dec 31, 2022 | 129.00B | 38.66B | 42.80% |
| Dec 31, 2021 | 90.34B | 35.13B | 63.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 126.23B |
| Dongbang Medical | 125.12B |
| Osang Healthcare Co.,Ltd | 96.48B |
| T&R Biofab | 32.73B |
| Humasis | 31.73B |
| Access Bio | 23.54B |
| Sugentech | 9.78B |
| P&S Robotics | 8.55B |